Stay Informed. Stay Competitive with FREE Insights on the Stock Market, Dow 30 & Emerging Opportunities. Get Free Email Updates

Stay Competitive With Stock Market Updates!

Get Free Updates

Amgen & Eli Lilly Enter Global Antibody Manufacturing Agreement For COVID-19 Antibody Therapies

By John F. Heerdink, Jr.

As per reports, Eli Lilly & Company and Amgen have entered an agreement for a global antibody manufacturing to increase global supply capacity for Lilly’s potential COVID-19 treatments. Lilly is currently researching a number of potential neutralizing antibodies for the prevention/treatment or both for COVID-19, either as monotherapy or in combination.

The collaboration between the companies will benefit to scale up production and serve more patients globally if Lilly’s antibody therapies succeed and receive approval. 

Esteban Santos, executive vice president of Operations at Amgen, added “We are proud to partner with Lilly and leverage our deep technical expertise in antibody development and, in particular, our strong capabilities in the scale-up and manufacturing of complex biologics. This is yet another example of the ways our industry is closely collaborating to combat this devastating disease and help patients around the world access new therapies.”

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.

Post View Count : 175
(Read Original Story: Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies in PR Newswire)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us